Insulin in the adjuvant breast cancer setting: a novel therapeutic target for lifestyle and pharmacologic interventions?
Goodwin
Pamela J
PJ
D001943:Breast Neoplasms / Q000097:blood* / Q000534:rehabilitation*; D015444:Exercise; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007328:Insulin / Q000097:blood* / Q000378:metabolism; D008019:Life Style; D008687:Metformin / Q000627:therapeutic use*; D053580:Muscle Strength; D010807:Physical Endurance; D011494:Protein Kinases / Q000187:drug effects; D012307:Risk Factors; D015996:Survival Rate; D058570:TOR Serine-Threonine Kinases
D007004:Hypoglycemic Agents; D007328:Insulin; D008687:Metformin; D011494:Protein Kinases; C546842:MTOR protein, human; D058570:TOR Serine-Threonine Kinases